{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:20:48Z","timestamp":1776216048547,"version":"3.50.1"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T00:00:00Z","timestamp":1521590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s11940-018-0493-6","type":"journal-article","created":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T04:29:28Z","timestamp":1521606568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Can Optical Coherence Tomography Be Used to Guide Treatment Decisions in Adult or Pediatric Multiple Sclerosis?"],"prefix":"10.1007","volume":"20","author":[{"given":"Jeffrey","family":"Lambe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olwen C.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiv","family":"Saidha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,21]]},"reference":[{"key":"493_CR1","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372:1502\u201317.","journal-title":"Lancet"},{"issue":"3","key":"493_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/ana.21423","volume":"64","author":"LK Fisniku","year":"2008","unstructured":"Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, Miszkiel KA, et al. Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol. 2008;64(3):247\u201354.","journal-title":"Ann Neurol"},{"issue":"5","key":"493_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ana.24487","volume":"78","author":"S Saidha","year":"2015","unstructured":"\u2022\u2022 Saidha S, Al-Louzi O, Ratchford JN, Bhargava P, Oh J, Newsome SD, et al. Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study. Ann Neurol. 2015;78(5):801\u201313. This study offers the strongest evidence of correlation between retinal and brain atrophy in multiple sclerosis (MS) patients","journal-title":"Ann Neurol"},{"issue":"12","key":"493_CR4","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/ncpneuro0950","volume":"4","author":"EM Frohman","year":"2008","unstructured":"Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ. Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol. 2008;4(12):664\u201375.","journal-title":"Nat Clin Pract Neurol"},{"key":"493_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/00006324-200007000-00009","volume":"77","author":"P Hrynchak","year":"2000","unstructured":"Hrynchak P, Simpson T. Optical coherence tomography: an introduction to the technique and it use. Optom Vis Sci. 2000;77:347\u201356.","journal-title":"Optom Vis Sci"},{"key":"493_CR6","first-page":"2520","volume":"40","author":"V Parisi","year":"1999","unstructured":"Parisi V, Manni G, Spadaro M, Colacino G, Restuccia R, Marchi S, et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci. 1999;40:2520\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Pt 2","key":"493_CR7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/brain\/awq346","volume":"134","author":"S Saidha","year":"2011","unstructured":"Saidha S, Syc SB, Ibrahim MA, Eckstein C, Warner CV, Farrell SK, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain. 2011;134(Pt 2):518\u201333.","journal-title":"Brain"},{"key":"493_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2147\/EB.S54131","volume":"8","author":"N Kale","year":"2016","unstructured":"Kale N. Optic neuritis as an early sign of multiple sclerosis. Eye Brain. 2016;8:195\u2013202.","journal-title":"Eye Brain"},{"key":"493_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/01658108308997307","volume":"3","author":"D Toussaint","year":"1983","unstructured":"Toussaint D, Perier O, Verstappen A, Bervoets S. Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol. 1983;3:211\u201320.","journal-title":"J Clin Neuroophthalmol"},{"issue":"6\u00a0pt. 2","key":"493_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1212\/WNL.26.6_Part_2.26","volume":"26","author":"F Ikuta","year":"1976","unstructured":"Ikuta F, Zimmerman HM. Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States. Neurology. 1976;26(6\u00a0pt. 2):26\u20138.","journal-title":"Neurology"},{"key":"493_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.exer.2008.05.017","volume":"87","author":"KS Shindler","year":"2008","unstructured":"Shindler KS, Ventura E, Dutt M, Rostami A. Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis. Exp Eye Res. 2008;87:208\u201313.","journal-title":"Exp Eye Res"},{"key":"493_CR12","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/brain\/awq080","volume":"133","author":"A Green","year":"2010","unstructured":"Green A, McQuaid S, Hauser SL, Allen IV, Lyness R. Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain. 2010;133:1591\u2013601.","journal-title":"Brain"},{"key":"493_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/00006982-199414050-00010","volume":"14","author":"JB Kerrison","year":"1994","unstructured":"Kerrison JB, Flynn T, Green WR. Retinal pathologic changes in multiple sclerosis. Retina. 1994;14:445\u201351.","journal-title":"Retina"},{"key":"493_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1212\/WNL.0b013e31827b1a1c","volume":"80","author":"JN Ratchford","year":"2013","unstructured":"Ratchford JN, Saidha S, Sotirchos ES, Oh J, Seigo MA, Eckstein C, et al. Active MS is associated with accelerated retinal ganglion cell\/inner plexiform layer thinning. Neurology. 2013;80:47\u201354.","journal-title":"Neurology"},{"key":"493_CR15","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ana.22005","volume":"67","author":"LS Talman","year":"2010","unstructured":"\u2022 Talman LS, Bisker ER, Sackel DJ, Long DA, Galetta KM, Ratchford JN, et al. Longitudinal study of vision and retinal nerve fiber layer thickness in MS. Ann Neurol. 2010;67:749\u201360. This study provided evidence for the correlation between retinal nerve fiber layer (RNFL) reduction and visual loss over time in multiple sclerosis","journal-title":"Ann Neurol"},{"issue":"pt 2","key":"493_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/brain\/awr264","volume":"135","author":"SB Syc","year":"2012","unstructured":"Syc SB, Saidha S, Newsome SD, Ratchford JN, Levy M, Ford E, et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain. 2012;135(pt 2):521\u201333.","journal-title":"Brain"},{"key":"493_CR17","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1177\/1352458511418630","volume":"17","author":"S Saidha","year":"2011","unstructured":"\u2022 Saidha S, Syc SB, Durbin MK, Eckstein C, Oakley JD, Meyer SA, et al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler. 2011;17:1449\u201363. This study was among the first to suggest superiority of ganglion cell and inner plexiform layer (GCIP) over RNFL with regard to structure-function relationships with visual function and disability in MS","journal-title":"Mult Scler"},{"key":"493_CR18","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1177\/1352458510371640","volume":"16","author":"SB Syc","year":"2010","unstructured":"Syc SB, Warner CV, Hiremath GS, Farrell SK, Ratchford JN, Conger A, et al. Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. Mult Scler. 2010;16:829\u201339.","journal-title":"Mult Scler"},{"key":"493_CR19","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1177\/1352458508090221","volume":"14","author":"J Toledo","year":"2008","unstructured":"Toledo J, Sepulcre J, Salinas-Alaman A, Garc\u00eda-Layana A, Murie-Fernandez M, Bejarano B, et al. Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis. Mult Scler. 2008;14:906\u201312.","journal-title":"Mult Scler"},{"key":"493_CR20","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1212\/01.wnl.0000295995.46586.ae","volume":"69","author":"E Gordon-Lipkin","year":"2007","unstructured":"Gordon-Lipkin E, Chodkowski B, Reich DS, Smith SA, Pulicken M, Balcer LJ, et al. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology. 2007;69:1603\u20139.","journal-title":"Neurology"},{"key":"493_CR21","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/S1474-4422(16)00068-5","volume":"15","author":"EH Martinez-Lapiscina","year":"2016","unstructured":"\u2022\u2022 Martinez-Lapiscina EH, Arnow S, Wilson JA, Saidha S, Preiningerova JL, Oberwahrenbrock T, et al. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study. Lancet Neurol. 2016;15:574\u201384. This study provides the strongest evidence to date to support the utility of OCT in predicting disability progression in MS","journal-title":"Lancet Neurol"},{"issue":"11","key":"493_CR22","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1093\/brain\/awt295","volume":"136","author":"P Bhargava","year":"2013","unstructured":"Bhargava P, Calabresi PA. The expanding spectrum of aetiologies causing retinal microcystic macular change. Brain. 2013;136(11):3212\u20134.","journal-title":"Brain"},{"key":"493_CR23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1177\/1352458515590646","volume":"22","author":"OA Al-Louzi","year":"2016","unstructured":"Al-Louzi OA, Bhargava P, Newsome SD, Balcer LJ, Frohman EM, Crainiceanu C, et al. Outer retinal changes following acute optic neuritis. Mult Scler. 2016;22:362\u201372.","journal-title":"Mult Scler"},{"key":"493_CR24","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/brain\/aws098","volume":"135","author":"JM Gelfand","year":"2012","unstructured":"\u2022 Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ. Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain. 2012;135:1786\u201393. This study was the first to demonstrate microcystic macular changes in multiple sclerosis, as well as identify a correlation between these changes and increased risk of disability progression","journal-title":"Brain"},{"issue":"11","key":"493_CR25","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S1474-4422(12)70213-2","volume":"11","author":"S Saidha","year":"2012","unstructured":"\u2022 Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ, et al. Relationship of the inner nuclear layer of the retina with clinicoradiologic disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol. 2012;11(11):963\u201372. This study demonstrates high correlation between inner nuclear layer thickness\/volume and inflammatory activity in MS","journal-title":"Lancet Neurol"},{"key":"493_CR26","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.24351","volume":"77","author":"I Gabilondo","year":"2015","unstructured":"\u2022 Gabilondo I, Martinez-Lapiscina EH, Fraga-Pumar E, Ortiz-Perez S, Torres-Torres R, Andorra M, et al. Dynamics of retinal injury after acute optic neuritis. Ann Neurol. 2015;77:517\u201328. Evidence from this study supports the potential role of trans-synaptic neurodegeneration in MS","journal-title":"Ann Neurol"},{"issue":"10","key":"493_CR27","doi-asserted-by":"publisher","first-page":"e78341","DOI":"10.1371\/journal.pone.0078341","volume":"8","author":"M Kaushik","year":"2013","unstructured":"Kaushik M, Wang CY, Barnett MH, Garrick R, Parratt J, Graham SL, et al. Inner nuclear layer thickening is inversely proportional to retinal ganglion cell loss in optic neuritis. PLoS One. 2013;8(10):e78341.","journal-title":"PLoS One"},{"key":"493_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/WNO.0b013e318261f7e7","volume":"32","author":"F Costello","year":"2012","unstructured":"Costello F, Van Stavern GP. Should optical coherence tomography be used to manage patients with multiple sclerosis? J Neuro-Ophthalmol. 2012;32:363\u201371.","journal-title":"J Neuro-Ophthalmol"},{"issue":"10","key":"493_CR29","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1177\/1352458514541509","volume":"20","author":"S Saidha","year":"2014","unstructured":"Saidha S, Calabresi PA. Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: yes. Mult Scler. 2014;20(10):1296\u20138.","journal-title":"Mult Scler"},{"issue":"10","key":"493_CR30","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1177\/1352458514541510","volume":"20","author":"TM Jenkins","year":"2014","unstructured":"Jenkins TM, Toosy AT. Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: no. Mult Scler. 2014;20(10):1299\u2013301.","journal-title":"Mult Scler"},{"key":"493_CR31","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/WNO.0b013e318238937f","volume":"31","author":"RE Sakai","year":"2011","unstructured":"Sakai RE, Feller DJ, Galetta SL, Balcer LJ. Vision in multiple sclerosis: the story, structure-functional correlations, and models for neuroprotection. J Neuroophthalmol. 2011;31:362\u201373.","journal-title":"J Neuroophthalmol"},{"issue":"6","key":"493_CR32","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ana.20851","volume":"59","author":"F Costello","year":"2006","unstructured":"\u2022 Costello F, Coupland S, Hodge W, Lorello GR, Koroluk J, Pan YI, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol. 2006;59(6):963\u20139. This study is the first to demonstrate a threshold of RNFL thickness, below which measurements predicted residual visual dysfunction following an episode of acute optic neuritis","journal-title":"Ann Neurol"},{"key":"493_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fneur.2014.00020","volume":"5","author":"N Serbecic","year":"2014","unstructured":"Serbecic N, Aboul-Enein F, Beutelspacher SC, et al. High-resolution spectral domain-optical coherence tomography in multiple sclerosis, part II\u2014the total macular volume. The first follow-up study over 2\u00a0years. Frontiers in Neurology. 2014;5:20.","journal-title":"Frontiers in Neurology"},{"key":"493_CR34","doi-asserted-by":"crossref","unstructured":"Balk LJ, Cruz-Herranz A, Albrecht P, Arnow S, Gelfand JM, Tewarie P, et al. Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study. J Neurol. 2016 Jul;263(7):1323\u201331.","DOI":"10.1007\/s00415-016-8127-y"},{"issue":"2","key":"493_CR35","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/WNO.0b013e318240204d","volume":"32","author":"KM Galetta","year":"2012","unstructured":"Galetta KM, Graves J, Talman LS, Lile DJ, Frohman EM, Calabresi PA, et al. Visual pathway axonal loss in benign multiple sclerosis: a longitudinal study. J Neuroophthalmol. 2012;32(2):116\u201323.","journal-title":"J Neuroophthalmol"},{"issue":"9","key":"493_CR36","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1177\/1352458513518626","volume":"20","author":"LJ Balk","year":"2014","unstructured":"Balk LJ, Tewarie P, Killestein J, Polman CH, Uitdehaag BMJ, Petzold A. Disease course heterogeneity and OCT in multiple sclerosis. Mult Scler. 2014;20(9):1198\u2013206.","journal-title":"Mult Scler"},{"issue":"3","key":"493_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3988\/jcn.2015.11.3.241","volume":"11","author":"YM Huang-Link","year":"2015","unstructured":"Huang-Link YM, Fredrikson M, Link H. Benign multiple sclerosis is associated with reduced thinning of the retinal nerve fiber and ganglion cell layers in non-optic-neuritis eyes. J Clin Neurol. 2015;11(3):241\u20137.","journal-title":"J Clin Neurol"},{"issue":"7","key":"493_CR38","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1177\/1352458515604496","volume":"22","author":"B Knier","year":"2016","unstructured":"Knier B, Berthele A, Buck D, Schmidt P, Zimmer C, M\u00fchlau M, et al. Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination. Mult Scler. 2016;22(7):893\u2013900.","journal-title":"Mult Scler"},{"issue":"5","key":"493_CR39","doi-asserted-by":"publisher","first-page":"e36847","DOI":"10.1371\/journal.pone.0036847","volume":"7","author":"JM Gelfand","year":"2012","unstructured":"Gelfand JM, Goodin DS, Boscardin WJ, Nolan R, Cuneo A, Green AJ. Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes. PLoS One. 2012;7(5):e36847.","journal-title":"PLoS One"},{"issue":"14","key":"493_CR40","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1177\/1352458513489757","volume":"19","author":"T Oberwahrenbrock","year":"2013","unstructured":"\u2022 Oberwahrenbrock T, Ringelstein M, Jentschke S, Deuschle K, Klumbies K, Bellmann-Strobl J, et al. Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome. Mult Scler. 2013;19(14):1887\u201395. This study supports the utility of GCIP measures in detecting retinal pathology in non-optic neuritis clinically isolated syndrome","journal-title":"Mult Scler"},{"key":"493_CR41","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1001\/archneurol.2009.265","volume":"66","author":"O Outteryck","year":"2009","unstructured":"Outteryck O, Zephir H, Defoort S, Bouyon M, Debruyne P, Bouacha I, et al. Optical coherence tomography in clinically isolated syndrome: no evidence of subclinical retinal axonal loss. Arch Neurol. 2009;66:1373\u20137.","journal-title":"Arch Neurol"},{"key":"493_CR42","doi-asserted-by":"crossref","unstructured":"Britze J, Pihl-Jensen G, Frederiksen JL. Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a systematic review and meta-analysis. J Neurology. 2017; [epub ahead of print]","DOI":"10.1007\/s00415-017-8531-y"},{"key":"493_CR43","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1212\/WNL.0b013e3181af78b8","volume":"73","author":"JN Ratchford","year":"2009","unstructured":"Ratchford JN, Quigg ME, Conger A, Frohman T, Frohman E, Balcor LJ. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology. 2009;73:302\u20138.","journal-title":"Neurology"},{"key":"493_CR44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ana.24030","volume":"75","author":"I Gabilondo","year":"2014","unstructured":"\u2022 Gabilondo I, Mart\u00ednez-Lapiscina EH, Mart\u00ednez-Heras E, Fraga-Pumar E, Llufriu S, Ortiz S, et al. Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Ann Neurol. 2014;75:98\u2013107. Evidence from this study supports the potential role of trans-synaptic neurodegeneration in MS","journal-title":"Ann Neurol"},{"issue":"7","key":"493_CR45","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1212\/WNL.0000000000001257","volume":"84","author":"J Oh","year":"2015","unstructured":"Oh J, Sotirchos ES, Saidha S, Whetstone A, Chen M, Newsome SD, et al. Relationships between quantitative spinal cord MRI and retinal layers in multiple sclerosis. Neurology. 2015;84(7):720\u20138.","journal-title":"Neurology"},{"key":"493_CR46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1001\/jamaneurol.2013.573","volume":"70","author":"S Saidha","year":"2013","unstructured":"Saidha S, Sotirchos ES, Oh J, Syc SB, Seigo MA, Shiee N, et al. Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol. 2013;70:34\u201343.","journal-title":"JAMA Neurol"},{"key":"493_CR47","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/1352458512457844","volume":"19","author":"H Zimmermann","year":"2013","unstructured":"\u2022 Zimmermann H, Freing A, Kaufhold F, Gaede G, Bohn E, Bock M, et al. Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations. Mult Scler. 2013;19:443\u201350. This study suggests disproportionate localized retinal tissue damage following acute optic neuritis in MS as evidenced by altered correlations between retinal measures and global relationships","journal-title":"Mult Scler"},{"issue":"1","key":"493_CR48","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.clinph.2015.06.025","volume":"127","author":"A Chili\u0144ska","year":"2016","unstructured":"Chili\u0144ska A, Ejma M, Turno-Kr\u0119cicka A, Guranski K, Misiuk-Hojlo M. Analysis of retinal nerve fibre layer, visual evoked potentials and relative afferent pupillary defect in multiple sclerosis patients. Clin Neurophysiol. 2016;127(1):821\u20136.","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"493_CR49","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3892\/etm.2016.3300","volume":"12","author":"R Pul","year":"2016","unstructured":"Pul R, Saadat M, Morbiducci F, Skripuletz T, Pul \u00dc, Brockmann D, et al. Longitudinal time-domain optic coherence study of retinal nerve fiber layer in IFN\u03b2-treated and untreated multiple sclerosis patients. Exp Ther Med. 2016;12(1):190\u2013200.","journal-title":"Exp Ther Med"},{"issue":"6","key":"493_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.oftal.2010.08.004","volume":"85","author":"E Garcia-Martin","year":"2010","unstructured":"Garcia-Martin E, Pueyo V, Fernandez J, Martin J, Ara JR, Almarcegui C, et al. Effect of treatment in loss of retinal nerve fiber layer in multiple sclerosis patients. Arch Soc Esp Oftalmol. 2010;85(6):209\u201314.","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"11","key":"493_CR51","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1093\/brain\/aww219","volume":"139","author":"B Knier","year":"2016","unstructured":"Knier B, Schmidt P, Aly L, Buck D, Berthele A, Muhlau M, et al. Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis. Brain. 2016;139(11):2855\u201363.","journal-title":"Brain"},{"issue":"6","key":"493_CR52","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1212\/WNL.0000000000003582","volume":"88","author":"J Button","year":"2017","unstructured":"\u2022\u2022 Button J, Al-Louzi O, Lang A, Bhargava P, Newsome SD, Frohman T, et al. Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: a retrospective study. Neurology. 2017;88(6):525\u201332. This study is among the first to longitudinally demonstrate the potential role of OCT in monitoring response to disease modifying therapies in multiple sclerosis","journal-title":"Neurology"},{"key":"493_CR53","doi-asserted-by":"crossref","unstructured":"Raza A, Mittal S, Sood GK. Interferon-associated retinopathy during the treatment of chronic hepatitis C: a systematic review. J Viral Hepat. 2013 Sep;20(9):593\u20139.","DOI":"10.1111\/jvh.12135"},{"issue":"3","key":"493_CR54","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00415-015-7879-0","volume":"263","author":"L Gaetani","year":"2016","unstructured":"Gaetani L, Menduno PS, Cometa F, Di Gregorio M, Sarchielli P, Cagini C, et al. Retinopathy during interferon-\u03b2 treatment for multiple sclerosis: case report and review of the literature. J Neurol. 2016;263(3):422\u20137.","journal-title":"J Neurol"},{"key":"493_CR55","doi-asserted-by":"crossref","unstructured":"Talmage GD, Coppes OJM, Javed A, Bernard J. Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: a prospective, non-randomized pilot study. PLoS One 2017:12(4):e0173299.","DOI":"10.1371\/journal.pone.0173299"},{"key":"493_CR56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.msard.2017.03.005","volume":"14","author":"A Kal","year":"2017","unstructured":"Kal A, O\u011fuz Ulusoy M, Horasanl\u0131 B, Cezairlio\u011flu \u015e, Kal \u00d6. Effect of fingolimod (FTY720) on choroidal thickness in patients with multiple sclerosis. Mult Scler Relat Disord. 2017;14:4\u20137.","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"493_CR57","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1212\/WNL.0b013e31827b9132","volume":"80","author":"R Nolan","year":"2013","unstructured":"\u2022 Nolan R, Gelfand JM, Green AJ. Fingolimod treatment in multiple sclerosis leads to increased macular volume. Neurology. 2013;80(2):139\u201344. This study demonstrates a correlation between macular volume and initiation of fingolimod therapy in MS","journal-title":"Neurology"},{"issue":"7","key":"493_CR58","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.ophtha.2012.12.040","volume":"120","author":"MA Zarbin","year":"2013","unstructured":"Zarbin MA, Jampol LM, Jager RD, Reder TR, Francis G, Collins W, et al. Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis. Ophthalmology. 2013;120(7):1432\u20139.","journal-title":"Ophthalmology"},{"issue":"5","key":"493_CR59","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMoa0909494","volume":"362","author":"L Kappos","year":"2010","unstructured":"Kappos L, Radue EW, O\u2019Connor P, Polman C, Hohlfeld R, Calabresi P, et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med. 2010;362(5):387\u2013401.","journal-title":"N Engl J Med"},{"key":"493_CR60","doi-asserted-by":"crossref","unstructured":"Nguyen AL, Lam J, White R, Carruthers R, Traboulsee A. Prospective study of retinal nerve fibre layer thickness in alemtuzumab treated multiple sclerosis patients. Neurology. 2016;86:16. supp P3.083","DOI":"10.1212\/WNL.86.16_supplement.P3.083"},{"issue":"24","key":"493_CR61","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1212\/WNL.0000000000002774","volume":"86","author":"A Cruz-Herranz","year":"2016","unstructured":"Cruz-Herranz A, Balk LJ, Oberwahrenbrock T, Saidha S, Mart\u00ednez-Lapiscina EH, Lagreze WA, et al. The APOSTEL recommendations for reporting quantitative optical coherence tomography studies. Neurology. 2016;86(24):2303\u20139.","journal-title":"Neurology"},{"key":"493_CR62","first-page":"148394","volume":"2011","author":"F Costello","year":"2011","unstructured":"Costello F. Evaluating the use of optical coherence tomography in optic neuritis. Mult Scler Int. 2011;2011:148394.","journal-title":"Mult Scler Int"},{"key":"493_CR63","doi-asserted-by":"crossref","first-page":"564627","DOI":"10.1155\/2012\/564627","volume":"2012","author":"AP Lange","year":"2012","unstructured":"Lange AP, Sadjadi R, Saeedi J, Lindley J, Costello F, Traboulsee AL. Time-domain and spectral-domain optical coherence tomography of retinal nerve fiber layer in MS patients and healthy controls. J Ophthalmol. 2012;2012:564627.","journal-title":"J Ophthalmol"},{"issue":"2","key":"493_CR64","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/WNO.0b013e3181facbbd","volume":"31","author":"GM Watson","year":"2011","unstructured":"Watson GM, Keltner JL, Chin EK, Harvey D, Nguyen A, Park SS. Comparison of retinal nerve fiber layer and central macular thickness measurements among five different optical coherence tomography instruments in patients with multiple sclerosis and optic neuritis. J Neuroophthalmol. 2011;31(2):111\u20136.","journal-title":"J Neuroophthalmol"},{"issue":"8","key":"493_CR65","doi-asserted-by":"publisher","first-page":"e22947","DOI":"10.1371\/journal.pone.0022947","volume":"6","author":"CV Warner","year":"2011","unstructured":"\u2022 Warner CV, Syc SB, Stankiewicz AM, Hiremath G, Farrell SK, Crainiceanu CM, et al. The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials. PLoS One. 2011;6(8):e22947. This study demonstrated poor levels of agreement between different OCT machines at an individual level, limiting their interchangeability in a clinical setting","journal-title":"PLoS One"},{"key":"493_CR66","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ajo.2012.11.025","volume":"155","author":"G Rebolleda","year":"2013","unstructured":"Rebolleda G, Gonz\u00e1lez-L\u00f3pez JJ, Mu\u00f1oz-Negrete FJ, Oblanca N, Costa-Frossard L, \u00c1lvarez-Cerme\u00f1o JC. Color-code agreement among stratus, cirrus, and spectralis optical coherence tomography in relapsing-remitting multiple sclerosis with and without prior optic neuritis. Am J Ophthalmol. 2013;155:890\u20137.","journal-title":"Am J Ophthalmol"},{"issue":"5\u20136","key":"493_CR67","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/08820538.2012.708808","volume":"27","author":"C Oliveira","year":"2012","unstructured":"Oliveira C, Cestari DM, Rizzo JF 3rd. The use of fourth generation optical coherence tomography in multiple sclerosis: a review. Semin Ophthalmol. 2012;27(5\u20136):187\u201391.","journal-title":"Semin Ophthalmol"},{"issue":"10","key":"493_CR68","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1007\/s00415-012-6466-x","volume":"259","author":"MA Seigo","year":"2012","unstructured":"Seigo MA, Sotirchos ES, Newsome S, Babiarz A, Eckstein C, Ford E, et al. In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques. J Neurol. 2012;259(10):2119\u201330.","journal-title":"J Neurol"},{"issue":"7","key":"493_CR69","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1364\/BOE.4.001133","volume":"4","author":"A Lang","year":"2013","unstructured":"Lang A, Carass A, Hauser M, et al. Retinal layer segmentation of macular OCT images using boundary classification. Biomedical Optics Express. 2013;4(7):1133\u201352.","journal-title":"Biomedical Optics Express"},{"key":"493_CR70","doi-asserted-by":"crossref","unstructured":"Bhargava P, Lang A, Al-Louzi O, Carass A, Prince J, Calabresi PA, et al. Applying an open-source segmentation algorithm to different OCT devices in multiple sclerosis patients and healthy controls: implications for clinical trials. Mult Scler Int. 2015;136295","DOI":"10.1155\/2015\/136295"},{"key":"493_CR71","first-page":"94130\u00a0M","volume":"9413","author":"A Lang","year":"2015","unstructured":"Lang A, Carass A, Al-Louzi O, Bhargava P, Ying HS, Calabresi PA, et al. Longitudinal graph-based segmentation of macular OCT using fundus alignment. Proc SPIE Int Soc Opt Eng. 2015;9413:94130\u00a0M.","journal-title":"Proc SPIE Int Soc Opt Eng"},{"issue":"2","key":"493_CR72","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1352458514538110","volume":"21","author":"S Schippling","year":"2015","unstructured":"Schippling S, Balk LJ, Costello F, Albrecht P, Balcer L, Calabresi PA, et al. Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria. Mult Scler. 2015;21(2):163\u201370.","journal-title":"Mult Scler"},{"key":"493_CR73","doi-asserted-by":"crossref","unstructured":"Lang A, Carass A, Al-Louzi O, Bhargava P, Solomon SD, Calabresi PA, et al. Combined registration and motion correction of longitudinal retinal OCT data. Proc SPIE Int Soc Opt Eng. 2016;9784","DOI":"10.1117\/12.2217157"},{"key":"493_CR74","first-page":"2332","volume":"40","author":"DS Chauhan","year":"1999","unstructured":"Chauhan DS, Marshall J. The interpretation of optic coherence tomography images of the retina. Invest Ophthalmol Vis Sci. 1999;40:2332\u201342.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"493_CR75","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00415-016-8127-y","volume":"263","author":"LJ Balk","year":"2016","unstructured":"Balk LJ, Cruz-Herranz A, Albrecht P, Arnow S, Gelfand JM, Tewarie P, et al. Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study. J Neurol. 2016;263:1323\u201331.","journal-title":"J Neurol"},{"key":"493_CR76","first-page":"9788","volume":"27","author":"BJ Antony","year":"2016","unstructured":"Antony BJ, Chen M, Carass A, Jedynak BM, Al-Louzi O, Solomon SD, et al. Voxel based morphometry in optical coherence tomography: validation & core findings. Proc SPIE Int Soc Opt Eng. 2016;27:9788.","journal-title":"Proc SPIE Int Soc Opt Eng"},{"issue":"1","key":"493_CR77","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.archger.2014.10.011","volume":"60","author":"L Gao","year":"2015","unstructured":"Gao L, Liu Y, Li X, Bai Q, Liu P. Abnormal retinal nerve fiber layer thickness and macula lutea in patients with mild cognitive impairment and Alzheimer\u2019s disease. Arch Gerontol Geriatr. 2015;60(1):162\u20137.","journal-title":"Arch Gerontol Geriatr"},{"key":"493_CR78","doi-asserted-by":"crossref","unstructured":"Roth NM, Saidha S, Zimmermann H, Brandt AU, Isensee J, Benkhellouf-Rutkowska A, et al. Photoreceptor layer thinning in idiopathic Parkinson\u2019s disease. Mov Disord 2014:29(9):1163\u20131170.","DOI":"10.1002\/mds.25896"},{"issue":"4","key":"493_CR79","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/acn3.46","volume":"1","author":"M Ringelstein","year":"2014","unstructured":"Ringelstein M, Albrecht P, S\u00fcdmeyer M, Harmel J, M\u00fcller AK, Keser N. Subtle retinal pathology in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2014;1(4):290\u20137.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"493_CR80","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/ene.12532","volume":"22","author":"K Huhn","year":"2015","unstructured":"\u2022\u2022 Huhn K, Lammer R, Oberwahrenbrock T, Lammer A, Waschbisch A, Gosar D, et al. Optical coherence tomography in patients with a history of juvenile multiple sclerosis reveals early retinal damage. Eur J Neurol. 2015;22(1):86\u201392. This study demonstrates retinal layer thinning in early stages of pediatric MS.","journal-title":"Eur J Neurol"},{"key":"493_CR81","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa067597","volume":"356","author":"C Renoux","year":"2007","unstructured":"Renoux C, Vukusic S, Mikaeloff M, Edan G, Clanet M, Dubois B, et al. Natural history of multiple sclerosis with childhood onset. N Engl J Med. 2007;356:2603\u201313.","journal-title":"N Engl J Med"},{"key":"493_CR82","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1001\/archneurol.2008.505","volume":"66","author":"MP Gorman","year":"2009","unstructured":"Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol. 2009;66:54\u20139.","journal-title":"Arch Neurol"},{"issue":"2","key":"493_CR83","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4103\/2319-4170.129269","volume":"37","author":"IJ Chou","year":"2014","unstructured":"Chou IJ, Whitehouse WP, Wang HS, Tanasescu R, Constantinescu CS. Diagnostic modalities in multiple sclerosis: perspectives in children. Biomed J. 2014;37(2):50\u20139.","journal-title":"Biomed J"},{"issue":"7","key":"493_CR84","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1177\/1352458511431725","volume":"18","author":"AJ Fay","year":"2012","unstructured":"Fay AJ, Mowry EM, Strober J, Waubant E. Relapse severity and recovery in early pediatric multiple sclerosis. Mult Scler. 2012;18(7):1008\u201312.","journal-title":"Mult Scler"},{"issue":"3","key":"493_CR85","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/ene.12327","volume":"21","author":"B Huppke","year":"2014","unstructured":"Huppke B, Ellenberger D, Rosewich H, Friede T, G\u00e4rtner J, Huppke P. Clinical presentation of pediatric multiple sclerosis before puberty. Eur J Neurol. 2014;21(3):441\u20136.","journal-title":"Eur J Neurol"},{"issue":"1","key":"493_CR86","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1542\/peds.2015-0028","volume":"136","author":"J O\u2019Mahony","year":"2015","unstructured":"O\u2019Mahony J, Marrie RA, Laporte A, Yeh EA, Bar-Or A, Phan C, et al. Recovery from central nervous system acute demyelination in children. Pediatrics. 2015;136(1):e115\u201323.","journal-title":"Pediatrics"},{"key":"493_CR87","doi-asserted-by":"crossref","unstructured":"Ghezzi A. Randomized control trials (RCTs) in pediatric multiple sclerosis: are they really necessary? Mult Scler 2017:23(7):1042\u20131043.","DOI":"10.1177\/1352458516684025"},{"issue":"5","key":"493_CR88","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1177\/1756285616656592","volume":"9","author":"K Rose","year":"2016","unstructured":"Rose K, Muller T. Children with multiple sclerosis should not become therapeutic hostages. Ther Adv Neurol Disord. 2016;9(5):389\u201395.","journal-title":"Ther Adv Neurol Disord"},{"issue":"2","key":"493_CR89","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1055\/s-0035-1549098","volume":"46","author":"RA Avery","year":"2015","unstructured":"Avery RA, Rajjoub RD, Trimboli-Heidler C, Waldman AT. Applications of optical coherence tomography in pediatric clinical neuroscience. Neuropediatrics. 2015;46(2):88\u201397.","journal-title":"Neuropediatrics"},{"key":"493_CR90","first-page":"673947","volume":"2013","author":"JA Pena","year":"2013","unstructured":"Pena JA, Lotze TE. Pediatric multiple sclerosis: current concepts and consensus definitions. Autoimmune Dis. 2013;2013:673947.","journal-title":"Autoimmune Dis"},{"issue":"7","key":"493_CR91","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1177\/1352458509104586","volume":"15","author":"EA Yeh","year":"2009","unstructured":"Yeh EA, Weinstock-Guttman B, Lincoff N, Reynolds J, Weinstock A, Madurai N, et al. Retinal nerve fiber thickness in inflammatory demyelinating diseases of childhood onset. Mult Scler. 2009;15(7):802\u201310.","journal-title":"Mult Scler"},{"key":"493_CR92","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1177\/0883073812447683","volume":"27","author":"U Yilmaz","year":"2012","unstructured":"Yilmaz U, Gucuyener K, Erin DM, Yazar Z, Gurkas E, Serdaroglu A, et al. Reduced retinal nerve fiber layer thickness and macular volume in pediatric multiple sclerosis. J Child Neurol. 2012;27:1517\u201323.","journal-title":"J Child Neurol"},{"issue":"3","key":"493_CR93","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/1352458516652497","volume":"23","author":"JS Graves","year":"2017","unstructured":"\u2022 Graves JS, Chohan H, Cedars B, Arnow S, Yiu H, Waubant E, et al. Sex differences and subclinical retinal injury in pediatric-onset MS. Mult Scler. 2017;23(3):447\u201355. This study demonstrated higher retinal layer atrophy in the eyes of pediatric MS patients with a prior history of optic neuritis than those without a history of optic neuritis","journal-title":"Mult Scler"},{"key":"493_CR94","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1212\/WNL.0b013e318240799a","volume":"78","author":"A Kerbrat","year":"2012","unstructured":"Kerbrat A, Aubert-Broche B, Fonov V, Narayanan S, Sled JG, Arnold DA, et al. Reduced head and brain size for age and disproportionately smaller thalami in child-onset MS. Neurology. 2012;78:194\u2013201.","journal-title":"Neurology"},{"issue":"8","key":"493_CR95","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3174\/ajnr.A3011","volume":"33","author":"M Calabrese","year":"2012","unstructured":"Calabrese M, Seppi D, Romualdi C, Rinaldi F, Alessio S, Perini P, et al. Gray matter pathology in MS: a 3-year longitudinal study in a pediatric population. AJNR Am J Neuroradiol. 2012;33(8):1507\u201311.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"7","key":"493_CR96","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/IJG.0b013e318193c2be","volume":"18","author":"FM Rauscher","year":"2009","unstructured":"Rauscher FM, Sekhon N, Feuer WJ, Budenz DL. Myopia affects retinal nerve fiber layer measurements as determined by optical coherence tomography. J Glaucoma. 2009;18(7):501\u20135.","journal-title":"J Glaucoma"},{"issue":"3","key":"493_CR97","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.3892\/etm.2017.4820","volume":"14","author":"Y Zha","year":"2017","unstructured":"Zha Y, Zhuang J, Lin D, Feng W, Zheng H, Cai J. Evaluation of myopia on retinal nerve fiber layer thickness measured by Spectralis optical coherence tomography. Exp Ther Med. 2017;14(3):2716\u201320.","journal-title":"Exp Ther Med"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-018-0493-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-018-0493-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-018-0493-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T05:12:31Z","timestamp":1719897151000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-018-0493-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,21]]},"references-count":97,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["493"],"URL":"https:\/\/doi.org\/10.1007\/s11940-018-0493-6","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,21]]},"assertion":[{"value":"21 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Jeffrey Lambe and Olwen Murphy declare no conflict of interest.Shiv Saidha has received consulting fees from Medical Logix for the development of CME programs in neurology and served on scientific advisory boards for Biogen-Idec, Genzyme, Genentech Corporation, and EMD Serono & Novartis. He has received equity compensation for consulting from JuneBrain LLC, a retinal imaging device developer. He receives research support from Genentech Corporation and the National MS Society and received support from the Race to Erase MS foundation. He is a member of the working committee of the International Multiple Sclerosis Visual System (IMSVISUAL) Consortium.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"9"}}